Angiotensin-Neprilysin Inhibition Versus Enalapril in Heart Failure

被引：0
|
作者：
Lyakishev, A. A.
机构：
来源：
KARDIOLOGIYA | 2014年 / 54卷 / 12期
关键词：
CONVERTING ENZYME-INHIBITION; NEUTRAL ENDOPEPTIDASE; DOUBLE-BLIND; RECEPTOR; LCZ696; TRIAL; OMAPATRILAT; SURVIVAL; ARNI;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：47 / 48
页数：2
相关论文
共 50 条
  • [1] Angiotensin-neprilysin inhibition versus enalapril in heart failure
    Ostios Garcia, L.
    REVISTA CLINICA ESPANOLA, 2015, 215 (01): : 55 - 56
  • [2] Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
    McMurray, John J. V.
    Packer, Milton
    Desai, Akshay S.
    Gong, Jianjian
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Rouleau, Jean L.
    Shi, Victor C.
    Solomon, Scott D.
    Swedberg, Karl
    Zile, Michael R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11): : 993 - 1004
  • [3] Efficacy of angiotensin-neprilysin inhibition versus enalapril in patient with heart failure with a reduced ejection fraction
    Ferrari, Laura
    Sada, Simona
    INTERNAL AND EMERGENCY MEDICINE, 2015, 10 (03) : 369 - 371
  • [4] Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure
    Velazquez, Eric J.
    Morrow, David A.
    DeVore, Adam D.
    Duffy, Carol I.
    Ambrosy, Andrew P.
    McCague, Kevin
    Rocha, Ricardo
    Braunwald, Eugene
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (06): : 539 - 548
  • [5] Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure
    Mc Causland, Finnian R.
    Lefkowitz, Marty
    Claggett, Brian
    Anavekar, Nagesh
    Senni, Michele
    Gori, Mauro
    Jhund, Pardeep S.
    McGrath, Martina
    Packer, Milton
    Shi, Victor
    van Veldhuisen, Dirk
    Zannad, Faiez
    Comin-Colet, Josep
    Pfeffer, Marc A.
    McMurray, John J.
    Solomon, Scott
    CIRCULATION, 2020, 142
  • [6] Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
    Gupta, Kartik
    Bajaj, Navkaranbir S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (12): : 1180 - 1181
  • [7] Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
    Solomon, S. D.
    McMurray, J. J. V.
    Anand, I. S.
    Ge, J.
    Lam, C. S. P.
    Maggioni, A. P.
    Martinez, F.
    Packer, M.
    Pfeffer, M. A.
    Pieske, B.
    Redfield, M. M.
    Rouleau, J. L.
    van Veldhuisen, D. J.
    Zannad, F.
    Zile, M. R.
    Desai, A. S.
    Claggett, B.
    Jhund, P. S.
    Boytsov, S. A.
    Comin-Colet, J.
    Cleland, J.
    Dungen, H. -D.
    Goncalvesova, E.
    Katova, T.
    Kerr Saraiva, J. F.
    Lelonek, M.
    Merkely, B.
    Senni, M.
    Shah, S. J.
    Zhou, J.
    Rizkala, A. R.
    Gong, J.
    Shi, V. C.
    Lefkowitz, M. P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (17): : 1609 - 1620
  • [8] Angiotensin-neprilysin inhibition in de novo heart failure - starting off strong
    Bhatt, Ankeet S.
    Vaduganathan, Muthiah
    Butler, Javed
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (02) : 313 - 314
  • [9] ANGIOTENSIN-NEPRILYSIN INHIBITION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION - A BAYESIAN INTERPRETATION
    Parcha, Vibhu
    Li, Peng
    Kalra, Rajat
    Arora, Garima
    Arora, Pankaj
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 805 - 805
  • [10] Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction
    Mc Causland, Finnian R.
    Lefkowitz, Martin P.
    Claggett, Brian
    Anavekar, Nagesh S.
    Senni, Michele
    Gori, Mauro
    Jhund, Pardeep S.
    McGrath, Martina M.
    Packer, Milton
    Shi, Victor
    Van Veldhuisen, Dirk J.
    Zannad, Faiez
    Comin-Colet, Josep
    Pfeffer, Marc A.
    McMurray, John J. V.
    Solomon, Scott D.
    CIRCULATION, 2020, 142 (13) : 1236 - 1245
12345